9 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Medline Quick Switch Valve with ENFit Connector

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

22 G X 1.00 IN. BD INSYTE¿ AUTOGUARD¿ SHIELDED IV CATHETER WITH BD VIALON¿

FDA Adverse Event
Injury ·BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.·Product code FOZ·October 14, 2015

QUANTUM RING FIXATION SYSTEM MODEL ISF

FDA 510(k)
FDA Class 2 ·Orthopedic

SINGLE USE SPLINTING TUBE, MODELS ST-Y0002-S, ST-Y0002-H, ST-Y0003-S AND ST-Y0003-H

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

ACCENT DR RF

FDA Adverse Event
Injury ·ST. JUDE MEDICAL, CRMD·Product code DXY·January 13, 2014

PARADIGM INSULIN INFUSION PUMP

FDA Adverse Event
Malfunction ·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code LZG·June 26, 2013

CENTRA BED

FDA Adverse Event
Malfunction ·HILL-ROM INC.·Product code FNL·July 28, 2011

TrueBeam Radiotherapy Delivery System version 2.0 and 2.5 EDGE Radiotherapy Delivery System version 2.0 and 2.5 Product Usage: The TrueBeam delivery systems are intended to provide radiotherapy and stereotactic radiosurgery for lesions, tumors, and conditions anywhere in the body where radiation treatment is indicated.

FDA Enforcement
Class II ·Terminated·Varian Medical Systems·October 10, 2018

Marathon Flow Directed Micro Catheter, UltraFlow HPC Flow Directed Micro Catheter Marathon Flow: The device is intended to access periphera and neurovasculature for the controlled selective infusion of physician-specified therapeutics agents such as embolization materials and of diagnostic materials such as contrast media. UltraFlow HPC Flow: The device is intended for the controlled selective infusion of physician-specified pharmacologic agents or contrast media into the distal vasculature of the peripheral and neuroanatomy. It is not intended for use in the coronary vasculature. Catalog No. 105-5055V02 105-5055V02 105-5055V05 105-5065V02 105-5065V05 105-5066V02 105-5066V05

FDA Enforcement
Class I ·Terminated·Micro Therapeutics Inc, Dba Ev3 Neurovascular·November 16, 2016